Published in Arch Neurol on June 01, 2009
Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc (2010) 1.85
Autoimmune chorea in adults. Neurology (2013) 1.11
Autoimmune autonomic ganglionopathy with reversible cognitive impairment. Arch Neurol (2011) 1.03
Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol (2012) 0.90
Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol (2012) 0.87
From smoking to lung cancer: the CHRNA5/A3/B4 connection. Oncogene (2010) 0.87
A model for lupus brain disease. Immunol Rev (2012) 0.85
Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci (2010) 0.83
The neurologic significance of celiac disease biomarkers. Neurology (2014) 0.83
Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: active immunization model in mice. Neurogastroenterol Motil (2012) 0.81
Autonomic involvement in subacute and chronic immune-mediated neuropathies. Autoimmune Dis (2013) 0.80
Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system. J Neuroinflammation (2016) 0.76
Anti-Hu antibodies activate enteric and sensory neurons. Sci Rep (2016) 0.75
Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren's Syndrome. Rheumatology (Sunnyvale) (2015) 0.75
P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments. Muscle Nerve (2016) 0.75
Paraneoplastic pandysautonomia as a manifestation of non-small cell lung cancer. Neurol Sci (2010) 0.75
A polymorphic DNA marker genetically linked to Huntington's disease. Nature (1984) 16.71
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med (2000) 3.57
Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc (1993) 3.40
Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc (2007) 3.32
Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol (2004) 2.91
Heterogeneity and complexity of native brain nicotinic receptors. Biochem Pharmacol (2007) 2.37
Experimental autoimmune autonomic neuropathy. J Neurophysiol (2003) 2.02
Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc (1989) 1.85
Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest (2003) 1.80
Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci (2004) 1.78
Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc (2006) 1.46
Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology (1998) 1.46
Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology (2006) 1.28
Involvement of the alpha3 subunit in central nicotinic binding populations. J Neurosci (2002) 1.26
Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol (2005) 1.24
Invited Article: Autonomic ganglia: target and novel therapeutic tool. Neurology (2008) 1.15
Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci (2001) 1.08
Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia. Brain Res (1998) 1.00
Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol (2008) 0.98
Use and interpretation of rheumatologic tests: a guide for clinicians. Mayo Clin Proc (1996) 0.85
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
The spectrum of neuromyelitis optica. Lancet Neurol (2007) 11.83
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med (2015) 5.03
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain (2010) 4.77
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain (2007) 4.50
Brain abnormalities in neuromyelitis optica. Arch Neurol (2006) 4.28
Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol (2008) 3.95
Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc (2007) 3.32
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol (2006) 3.26
Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol (2012) 2.95
Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol (2004) 2.91
Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol (2008) 2.80
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc (2013) 2.64
Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol (2012) 2.49
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol (2013) 2.46
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology (2013) 2.34
Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol (2003) 2.29
Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med (2008) 2.26
Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol (2010) 2.26
Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys (2006) 2.12
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci U S A (2011) 2.11
Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol (2013) 2.10
Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc (2003) 2.09
Experimental autoimmune autonomic neuropathy. J Neurophysiol (2003) 2.02
Do not treat from CIS onset: evaluate disease course and prognosis first--yes. Mult Scler (2012) 2.01
Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology (2012) 2.00
Hyperhidrosis: evolving therapies for a well-established phenomenon. Mayo Clin Proc (2005) 1.99
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
The spectrum of autoimmune autonomic neuropathies. Ann Neurol (2003) 1.93
Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc (2010) 1.85
Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol (2003) 1.79
Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci (2004) 1.78
Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve (2006) 1.78
Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol (2013) 1.78
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet (2011) 1.77
Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol (2011) 1.77
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol (2009) 1.73
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet (2012) 1.73
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol (2011) 1.65
Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol (2009) 1.61
Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol (2010) 1.60
Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol (2008) 1.59
Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol (2009) 1.55
Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol (2005) 1.51
Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol (2011) 1.49
Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol (2009) 1.48
Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc (2006) 1.46
Striational antibodies in a paraneoplastic context. Muscle Nerve (2013) 1.46
CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology (2011) 1.41
Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics (2011) 1.39
Neuromyelitis optica: changing concepts. J Neuroimmunol (2007) 1.39
Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol (2004) 1.38
Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol (2002) 1.36
Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol (2012) 1.34
Effects of chronic sympathectomy on vascular function in the human forearm. J Appl Physiol (1985) (2002) 1.34
Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res (2004) 1.33
Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol (2004) 1.30
Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry (2012) 1.29
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol (2009) 1.29
Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol (2010) 1.28
GABAB receptor autoantibody frequency in service serologic evaluation. Neurology (2013) 1.28
Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology (2006) 1.28
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol (2009) 1.27
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro Oncol (2013) 1.20
Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol (2008) 1.17
Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun (2012) 1.16